Israeli medical-aesthetic devices maker Endymed has appointed Bill Scott as president of its US subsidiary.
Scott will lead Endymed’s sales teams in the United States, ensuring customers receive sales and account management support.
Scott was selected to lead Endymed operations in the United States and Canada as part of the company’s growth plan of expanding its operations in North America and, in particular, the United States.
Scott has over 25 years of experience in the medical esthetics field. He was previously at Palomar Medical, where he served as West US and Canada sales director.
In 2013, Scott was recruited as North American vice president of sales at Alma. After rebuilding and stabilizing the sales force, the company attained annual double-digit growth achieving a successful IPO launch in 2017.
Most recently, as VP of North America sales at Viora Medical, Scott supported revenue growth that followed with an acquisition resulting from success in the US market.
The company believes that Scott’s appointment will drive its US growth plan and help secure a significant reach in the North American market.
Endymed offers energy-based medical aesthetic treatment systems for professional and consumer markets.
The first product line addresses the professional medical market – doctors, medical clinics, and aesthetic providers, all utilizing the company’s products to treat their patients. The second product line is intended for the consumer market.